BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28653753)

  • 1. The development of a magnetic resonance imaging index for fistulising Crohn's disease.
    Samaan MA; Puylaert CAJ; Levesque BG; Zou GY; Stitt L; Taylor SA; Shackelton LM; Vandervoort MK; Khanna R; Santillan C; Rimola J; Hindryckx P; Nio CY; Sandborn WJ; D'Haens G; Feagan BG; Jairath V; Stoker J
    Aliment Pharmacol Ther; 2017 Sep; 46(5):516-528. PubMed ID: 28653753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn's Disease.
    Hindryckx P; Jairath V; Zou G; Feagan BG; Sandborn WJ; Stoker J; Khanna R; Stitt L; van Viegen T; Shackelton LM; Taylor SA; Santillan C; Mearadji B; D'Haens G; Richard MP; Panes J; Rimola J
    Gastroenterology; 2019 Nov; 157(5):1233-1244.e5. PubMed ID: 31336124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the modified Van Assche index for assessing response to anti-TNF therapy with MRI in perianal fistulizing Crohn's disease.
    van Rijn KL; Lansdorp CA; Tielbeek JAW; Nio CY; Buskens CJ; D'Haens GRAM; Löwenberg M; Stoker J
    Clin Imaging; 2020 Feb; 59(2):179-187. PubMed ID: 31821976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Standardised Scoring Conventions on Inter-rater Reliability in the Endoscopic Evaluation of Crohn's Disease.
    Dubcenco E; Zou G; Stitt L; Baker JP; Jeejeebhoy KN; Kandel G; Kim YI; Grover SC; McDonald JW; Shackelton LM; Khanna R; D'Haens G; Sandborn WJ; Feagan BG; Levesque BG
    J Crohns Colitis; 2016 Sep; 10(9):1006-14. PubMed ID: 27385400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease.
    Khanna R; Zou G; D'Haens G; Rutgeerts P; McDonald JW; Daperno M; Feagan BG; Sandborn WJ; Dubcenco E; Stitt L; Vandervoort MK; Donner A; Luo A; Levesque BG
    Gut; 2016 Jul; 65(7):1119-25. PubMed ID: 25935574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by Magnetic Resonance Enterography.
    Jairath V; Ordas I; Zou G; Panes J; Stoker J; Taylor SA; Santillan C; Horsthuis K; Samaan MA; Shackelton LM; Stitt LW; Hindryckx P; Khanna R; Sandborn WJ; D'Haens G; Feagan BG; Levesque BG; Rimola J
    Inflamm Bowel Dis; 2018 Jan; 24(2):440-449. PubMed ID: 29361096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scoring Indices for Perianal Fistulising Crohn's Disease: A Systematic Review.
    Vuyyuru SK; Solitano V; Singh S; Hanzel J; Macdonald JK; Danese S; Peyrin Biroulet L; Ma C; Jairath V
    J Crohns Colitis; 2024 Jun; 18(6):836-850. PubMed ID: 38126903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging and clinical assessments for perianal Crohn's disease: gain and limits.
    Garros A; Siproudhis L; Tchoundjeu B; Rohou T; Brochard C; Wallenhorst T; Bretagne JF; Bouguen G
    Dig Liver Dis; 2014 Dec; 46(12):1072-6. PubMed ID: 25192603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fistulizing perianal Crohn's disease: contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy.
    Savoye-Collet C; Savoye G; Koning E; Dacher JN; Lerebours E
    Inflamm Bowel Dis; 2011 Aug; 17(8):1751-8. PubMed ID: 21744430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease.
    Thomassin L; Armengol-Debeir L; Charpentier C; Bridoux V; Koning E; Savoye G; Savoye-Collet C
    World J Gastroenterol; 2017 Jun; 23(23):4285-4292. PubMed ID: 28694669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Pediatric MRI-Based Perianal Crohn Disease (PEMPAC) Index-A Report from the ImageKids Study.
    Choshen S; Turner D; Pratt LT; Precel R; Greer ML; Castro DA; Assa A; Martínez-León MI; Herman-Sucharska I; Coppenrath E; Konen O; Davila J; Bekhit E; Alsabban Z; Focht G; Gavish M; Griffiths A; Cytter-Kuint R
    Inflamm Bowel Dis; 2022 May; 28(5):700-709. PubMed ID: 34151950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perianal Imaging in Crohn Disease: Current Status With a Focus on MRI, From the
    Greer MC; Taylor SA
    AJR Am J Roentgenol; 2022 May; 218(5):781-792. PubMed ID: 34549607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability of Pelvic Magnetic Resonance Imaging to Predict Clinical Course of Perianal Fistula in Paediatric Crohn's Disease Patients.
    Kim PH; Kim SH; Cho YA; Yoon HM; Lee JS; Jung AY; Oh SH; Kim DY; Namgoong JM; Kim KM
    J Crohns Colitis; 2021 Jul; 15(7):1152-1160. PubMed ID: 33411884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials.
    Crowley E; Ma C; Guizzetti L; Zou G; Lewindon PJ; Gee MS; Hyams JS; Rosen MJ; von Allmen D; de Buck van Overstraeten A; Shackelton LM; Remillard J; Schleicher L; Dillman JR; Rimola J; Taylor SA; Fletcher JG; Church PC; Feagan BG; Griffiths AM; Jairath V; Greer MC
    Inflamm Bowel Dis; 2024 Mar; 30(3):357-369. PubMed ID: 37524088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-based score helps in assessing the severity and in follow-up of pediatric patients with perianal Crohn disease.
    Kulkarni S; Gomara R; Reeves-Garcia J; Hernandez E; Restrepo R
    J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):252-7. PubMed ID: 24121148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of histological assessments of disease activity in UC.
    Mosli MH; Feagan BG; Zou G; Sandborn WJ; D'Haens G; Khanna R; Behling C; Kaplan K; Driman DK; Shackelton LM; Baker KA; MacDonald JK; Vandervoort MK; Samaan MA; Geboes K; Valasek MA; Pai R; Langner C; Riddell R; Harpaz N; Sewitch M; Peterson M; Stitt LW; Levesque BG
    Gut; 2015 Nov; 64(11):1765-73. PubMed ID: 25360036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of adalimumab in perianal fistulas in crohn's disease patients naive to anti-TNF therapy.
    Castaño-Milla C; Chaparro M; Saro C; Barreiro-de Acosta M; García-Albert AM; Bujanda L; Martín-Arranz MD; Carpio D; Muñoz F; Manceñido N; García-Planella E; Piqueras M; Calvet X; Cabriada JL; Botella B; Bermejo F; Gisbert JP
    J Clin Gastroenterol; 2015 Jan; 49(1):34-40. PubMed ID: 25485513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of the Fifth Scientific Workshop of the ECCO [II]: Clinical Aspects of Perianal Fistulising Crohn's Disease-the Unmet Needs.
    Gecse KB; Sebastian S; Hertogh Gd; Yassin NA; Kotze PG; Reinisch W; Spinelli A; Koutroubakis IE; Katsanos KH; Hart A; van den Brink GR; Rogler G; Bemelman WA
    J Crohns Colitis; 2016 Jul; 10(7):758-65. PubMed ID: 26826183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance enterography has good inter-rater agreement and diagnostic accuracy for detecting inflammation in pediatric Crohn disease.
    Church PC; Greer MC; Cytter-Kuint R; Doria AS; Griffiths AM; Turner D; Walters TD; Feldman BM
    Pediatr Radiol; 2017 May; 47(5):565-575. PubMed ID: 28283726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the effectiveness of infliximab on perianal fistulizing Crohn's disease by magnetic resonance imaging.
    Yan X; Zhu M; Feng Q; Yan Y; Peng J; Xu X; Xu A; Ran Z
    Gastroenterol Rep (Oxf); 2019 Feb; 7(1):50-56. PubMed ID: 30792866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.